____Check this box if no longer subject to Section 16. Form 4 or Form 5
obligations may continue. See Instruction 1(b).
U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 4
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange act of 1934,
Section 17(a) of the Public Utility Holding Company act of 1935 or Section
30(f) of the Investment Company Act of 1940
1. Name and Address of Reporting Person
Glassman Iris S.
(Last) (First) (Middle)
383 Route 46 West
(Street)
Fairfield NJ 07004
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol "BPRX"
BRADLEY PHARMACEUTICALS, INC.
3. IRS or Social Security Number of Reporting Person (Voluntary)
4. Statement for Month/Year 07/2000
5. If Amendment, Date of Original (Month/Year)
6. Relationship of Reporting Person to Issuer (Check all applicable)
__X__Director ______10 % Owner
__X__Officer (give title ______Other (specify below)
below)
Treasurer
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially
Owned
1. Title of Security (Instr.3)
(1) Class B Common Stock
(2) Class B Common Stock
(3) Common Stock
(4) Common Stock
(5) Class B Common Stock Transferred to Bradley Glassman Form 3
(6) Common Stock Transferred to Bradley Glassman Form 3
(7) Common Stock
(8) Class B Common Stock
(9) Common Stock
(10) Common Stock
(11) Common Stock
(12) Common Stock
(13) Common Stock
2. Transaction Date (Month/Day/Year)
(1)
(2)
(3)
(4)
(5) 07/31/00
(6) 07/31/00
(7)
(8)
(9)
(10)
(11)
(12)
(13)
3. Transaction Code (Instr.8)
(1)
(2)
(3)
(4)
(5) Code J
(6) Code J
(7)
(8)
(9)
(10)
(11)
(12)
(13)
4. Securities Acquired (A) or Disposed of (D) (Instr.3,4 and 5)
(1)
(2)
(3)
(4)
(5) Amount - 20,880 (D) Price - 0
(6) Amount - 15,620 (D) Price - 0
(7)
(8)
(9)
(10)
(11)
(12)
(13)
5. Amount of Securities Beneficially Owned at End of Month (Instr.3 and 4)
(1) 16,403
(2) 280,838
(3) 30,000
(4) 6,800
(5) -
(6) -
(7) 8,530
(8) 13,400
(9) 4,100
(10) 6,400
(11) 18,200
(12) 1,600
(13) 15,350
6. Ownership Form: Direct (D) or Indirect (I)
(1) (D)
(2) (I)
(3) (D)
(4) (I)
(5) (I)
(6) (I)
(7) (I)
(8) (D)
(9) (D)
(10) (I)
(11) (I)
(12) (I)
(13) (I)
7. Nature of Indirect Beneficial Ownership (Instr.4)
(1)
(2) By Spouse
(3) With Spouse
(4) By IRA
(5) Trustee for Bradley Glassman Trust
(6) Trustee for Bradley Glassman Trust
(7) Trustee for Grandchildren Trust
(8) With Spouse
(9) With Spouse
(10) Trustee for Stacey Glassman Trust
(11) Trustee for Heath Glassman Trust
(12) By Spouse
(13) With Spouse
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
(Print or Type Responses)
FORM 4 (continued)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr.3)
Options (right to buy)
2. Conversion or Exercise Price of Derivative Security
(1) 1.3125
(2) 1.3125
(3) 1.3125
(4) 1.3125
(5) 1.3125
(6) 1.3125
(7) 1.3125
(8) 1.3125
(9) 1.3125
(10) 1.3125
(11) 1.3125
(12) 1.3125
(13) 1.3125
(14) 1.3125
(15) 1.3125
(16) 1.0625
3. Transaction Date (Month/Day/Year)
4. Transaction Code (Instr.8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr.3,4 and 5)
6. Date Exercisable and Expiration Date (Month/Day/Year)
(1) Exercisable - 11/12/92 Expiration - 11/12/01
(2) Exercisable - 11/12/93 Expiration - 11/12/01
(3) Exercisable - 11/12/94 Expiration - 11/12/01
(4) Exercisable - 10/01/93 Expiration - 09/30/02
(5) Exercisable - 10/01/94 Expiration - 09/30/02
(6) Exercisable - 10/01/95 Expiration - 09/30/02
(7) Exercisable - 04/12/95 Expiration - 04/11/04
(8) Exercisable - 04/12/96 Expiration - 04/11/04
(9) Exercisable - 04/12/97 Expiration - 04/11/04
(10) Exercisable - 12/30/95 Expiration - 12/29/04
(11) Exercisable - 12/30/96 Expiration - 12/29/04
(12) Exercisable - 12/30/97 Expiration - 12/30/04
(13) Exercisable - 09/12/96 Expiration - 09/11/05
(14) Exercisable - 09/12/97 Expiration - 09/11/05
(15) Exercisable - 09/12/98 Expiration - 09/11/05
(16) Exercisable - 12/05/95 Expiration - 12/04/05
7. Title and Amount of Underlying Securities
(1) Title - Common Stock Number of Shares - 5,731
(2) Title - Common Stock Number of Shares - 5,731
(3) Title - Common Stock Number of Shares - 5,730
(4) Title - Common Stock Number of Shares - 3,333
(5) Title - Common Stock Number of Shares - 3,333
(6) Title - Common Stock Number of Shares - 3,334
(7) Title - Common Stock Number of Shares - 16,666
(8) Title - Common Stock Number of Shares - 16,667
(9) Title - Common Stock Number of Shares - 16,667
(10) Title - Common Stock Number of Shares - 16,666
(11) Title - Common Stock Number of Shares - 16,667
(12) Title - Common Stock Number of Shares - 16,667
(13) Title - Common Stock Number of Shares - 6,000
(14) Title - Common Stock Number of Shares - 6,000
(15) Title - Common Stock Number of Shares - 6,000
(16) Title - Common Stock Number of Shares - 22,878
8. Price of Derivative Security (Instr.5)
(1) 1.3125
(2) 1.3125
(3) 1.3125
(4) 1.3125
(5) 1.3125
(6) 1.3125
(7) 1.3125
(8) 1.3125
(9) 1.3125
(10) 1.3125
(11) 1.3125
(12) 1.3125
(13) 1.3125
(14) 1.3125
(15) 1.3125
(16) 1.0625
9. Number of Derivative Securities Beneficially Owned at End of Month (Instr.4)
(1) 5,731
(2) 5,731
(3) 5,730
(4) 3,333
(5) 3,333
(6) 3,334
(7) 16,666
(8) 16,667
(9) 16,667
(10) 16,666
(11) 16,667
(12) 16,667
(13) 6,000
(14) 6,000
(15) 6,000
(16) 22,878
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr.4)
(D)
11. Nature of Indirect Beneficial Ownership (Instr.4)
Explanation of Responses:
/s/Iris S. Glassman August 9, 2000
------------------------------- --------------
**Signature of Reporting Person Date
** Intentional misstatements or omissions of facts constitute Federal
Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space provided is insufficient, see Instruction 6 for procedure.
SEC 1474 (3/91)
